InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,709.54
(
0.01%
)
US TECH 100
19,198.80
(
-0.41%
)
Dow Jones
42,196.52
(
0.09%
)
Brent Oil
75.44
(
1.10%
)
Bitcoin
61,276.60
(
1.08%
)
Post# of 447
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Jonathan Robinson

Send PM Follow Ignore
Followers 5
Posts 624
Boards Moderated 0
Alias Born 09/13/2004

Jonathan Robinson

Re: None

Thursday, 02/22/2007 7:53:19 AM

Thursday, February 22, 2007 7:53:19 AM

Post# of 447
After talking with FDA shortly, hoping to go back into Ph II with liquid dose while working on new tablet/gel formulations. Would then do a small bioequivalency study to move forward. Seems like a reasonable plan to me - thoughts?

Jon
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM

Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM

Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM

ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM

Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM

Start posting your company's news
Only $200 per official company press release!